pharmacie et médicaments – Traitement des patients atteints de myélome multiple en échec thérapeutique

This written question concerns access to treatments for patients with multiple myeloma who have not responded to previous therapies. It highlights the challenges faced by these patients in obtaining effective care. The question seeks information on the availability and accessibility of advanced treatment options for multiple myeloma, potentially impacting patients, healthcare providers, and pharmaceutical companies.